Tech Company Financing Transactions
Invitae Funding Round
Invitae closed a $40 million Series E funding round on 12/12/2013. Backers included Casdin Capital, Genesys Capital and Genomic Health.
Transaction Overview
Company Name
Announced On
12/12/2013
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series E
Investors
Proceeds Purpose
Invitae will use the financing to accelerate the ongoing development of the company's clinical genetic tests for hereditary disorders, including oncology, neurology and pediatric medicine.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1400 16th St.
San Francisco, CA 94103
USA
San Francisco, CA 94103
USA
Phone
Website
Email Address
Overview
Invitae Corporation (NYSE: NVTA), a genetic information company, focuses on bringing comprehensive genetic information into mainstream medical practice to enhance the quality of healthcare in the United States, Canada, Israel, and internationally.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Randy Scott
Chief Marketing Officer
Robert Nussbaum
Browse more venture capital transactions:
Prev: 12/12/2013: Highlight App venture capital transaction
Next: 12/12/2013: TopLog venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document funding rounds that are announced publicly. VC transactions on this site are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs